Penobscot Nation's pharmacy business investigated

The Penobscot Nation's mail-order pharmacy program is being investigated by the Maine Board of Pharmacy for its sale of drugs over the Internet.

PIN Rx sold prescription drugs through websites without requiring a face-to-face visit with a physician, according to the state. The tribe was offered a settlement to pay a fine of $183,000 for nearly 200,000 questionable prescriptions.

The tribe rejected the offer, an attorney said. It would have required an admission of wrongdoing.

The tribe launched PIN Rx in November 2005. Gov. John Baldacci (D) backed the business, which came with $1 million in state funds. Republican lawmakers are questioning the state's vinvolvement.

Get the Story:
State GOP leaders question PIN Rx oversight (The Bangor Daily News 2/6)
Penobscot mail-order pharmacy under investigation (AP 2/5)
Legislators Want Answers In PIN Rx Probe (WMTW 2/5)
Governor's Statement Concerning PIN Rx Investigation (WMTW 2/5)

Relevant Links:
Penobscot Nation - http://www.penobscotnation.org

Related Stories:
Penobscot Nation got tribe's help with pharmacy (11/29)
Grand opening for Penobscot Nation's pharmacy (11/18)
Maine tribe starts prescription drug business (09/07)
Penobscot Nation to sell prescription drugs (06/29)
Plan to include tribe in drug import program panned (03/31)
Minnesota tribes move forward with pharmacy efforts (03/07)
Penobscot Nation to open statewide pharmacy (02/24)
Inter-tribal prescription drug trade gets boost (2/18)
Minnesota governor wants tribes to import drugs (2/17)
Red Lake Band discusses trade with First Nations (2/10)
Prescription drug cards provide discounts for Natives (10/14)
Maine designates Penobscot Nation as drug importer (10/01)
Indian-owned business sells discount drugs (8/1)
This story is tagged under:
Search
Share this Story!

You are enjoying stories from the Indianz.Com Archive, a collection dating back to 2000. Some outgoing links may no longer work due to age.

All stories in the Indianz.Com Archive are available for publishing via Creative Commons License: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)